A Cellular Mechanism to Detect and Alleviate Reductive Stress.
Antioxidants
/ metabolism
Carrier Proteins
/ genetics
Cell Differentiation
HEK293 Cells
Homeostasis
Humans
Kelch-Like ECH-Associated Protein 1
/ metabolism
Mitochondria
Muscle Development
/ physiology
Myoblasts
/ metabolism
NF-E2-Related Factor 2
/ metabolism
Oxidative Stress
/ physiology
Reactive Oxygen Species
/ metabolism
Signal Transduction
Ubiquitin-Protein Ligases
/ metabolism
Ubiquitination
FEM1B
FNIP1
KEAP1
mitochondria
oxidative stress
proteasome
reactive oxygen
reductive stress
ubiquitin
Journal
Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066
Informations de publication
Date de publication:
01 10 2020
01 10 2020
Historique:
received:
18
12
2019
revised:
28
05
2020
accepted:
18
08
2020
pubmed:
18
9
2020
medline:
18
5
2021
entrez:
17
9
2020
Statut:
ppublish
Résumé
Metazoan organisms rely on conserved stress response pathways to alleviate adverse conditions and preserve cellular integrity. Stress responses are particularly important in stem cells that provide lifetime support for tissue formation and repair, but how these protective systems are integrated into developmental programs is poorly understood. Here we used myoblast differentiation to identify the E3 ligase CUL2
Identifiants
pubmed: 32941802
pii: S0092-8674(20)31076-X
doi: 10.1016/j.cell.2020.08.034
pii:
doi:
Substances chimiques
Antioxidants
0
Carrier Proteins
0
FNIP1 protein, human
0
Kelch-Like ECH-Associated Protein 1
0
NF-E2-Related Factor 2
0
Reactive Oxygen Species
0
Ubiquitin-Protein Ligases
EC 2.3.2.27
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
46-61.e21Subventions
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NIH HHS
ID : S10 OD020062
Pays : United States
Organisme : NIH HHS
ID : S10 OD018174
Pays : United States
Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interest M.R. is a co-founder and consultant to Nurix, a publicly traded company in the ubiquitin space. D.K.N. is a co-founder, shareholder, and adviser of Frontier Medicines.